Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Myomo, Inc. is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke. Its MyoPro myoelectric limb orthosis is a powered brace that supports a weakened and deformed arm for functional use. The MyoPro is an elbow/wrist/Hand orthosis, which supports the arm and helps to bend and straighten the arm at the elbow. The brace provides assistive function for joint motion that enables a user to self-initiate and control movements of a partially paralyzed arm using their own muscle signals. When the user tries to bend their arm, sensors in the brace detect the weak muscle signal, which activates the motor to amplify their weak muscle signal to help bend and move their arm. The brace uses non-invasive skin sensors.
Website: myomo.com



Growth: Good revenue growth rate >200%, there is acceleration compared to average historical growth rates 46.3%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is negative, -20.4%. On average the margin is improving steadily. Gross margin is high, +71.2%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.06 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 147.5% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 111.3% higher than minimum and 86.8% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 10.5x by EV / Sales multiple

Key Financials (Download financials)

Ticker: MYO
Share price, USD:  (0.0%)0.9228
year average price 2.3714  


year start price 6.0001 2025-02-08

max close price 6.3100 2025-02-13

min close price 0.7200 2025-11-20

current price 0.9228 2026-02-07
Common stocks: 7 349 122

Dividend Yield:  0.0%
EV / Sales: -0.2x
Margin (EBITDA LTM / Revenue): -20.4%
Fundamental value created in LTM:
Market Cap ($m): 7
Net Debt ($m): -16
EV (Enterprise Value): -9
Price to Book: 0.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-11-10seekingalpha.com

Myomo, Inc. (MYO) Q3 2025 Earnings Call Transcript

2025-06-30https://www.marketscreener.c

Myomo, Inc.(NYSEAM:MYO) added to Russell 3000 Growth Index

2025-03-10zacks.com

Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates

2025-03-10seekingalpha.com

Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript

2024-11-06zacks.com

Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates

2024-05-08Seeking Alpha

Myomo, Inc. (MYO) Q1 2024 Earnings Call Transcript

2024-05-01Business Wire

Myomo to Report First Quarter Financial Results on May 8, 2024

2024-03-10Seeking Alpha

Myomo, Inc.: In Motion To Accelerating Revenue Growth

2024-03-07Zacks Investment Research

Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates

2023-12-20Zacks Investment Research

What Makes Myomo, Inc. (MYO) a Good Fit for 'Trend Investing'
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-10 2025-08-11 2024-11-06 2024-08-06 2024-05-08 2023-11-07 2023-08-09 2023-05-10 2022-11-10
acceptedDate 2025-11-10 16:15:52 2025-08-11 16:15:27 2025-03-10 16:28:56 2024-11-06 16:15:23 2024-08-06 16:15:26 2024-05-08 16:10:58 2024-03-07 21:38:51 2023-11-07 17:29:50 2023-08-09 16:18:01 2023-05-10 16:24:01 2023-03-13 15:49:17 2022-11-10 16:28:57 2022-03-11 14:51:31 2021-03-10 16:21:17
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 10M 10M 33M 9M 8M 4M 19M 5M 6M 3M 16M 4M 14M 8M
costOfRevenue 4M 4M 9M 2M 2M 1M 6M 2M 2M 1M 5M 1M 4M 3M
grossProfit 6M 6M 23M 7M 5M 2M 13M 3M 4M 2M 10M 3M 10M 5M
grossProfitRatio 0.638 0.627 0.754 0.708 0.612 0.687 0.718 0.67 0.665
researchAndDevelopmentExpenses 2M 2M 5M 1M 1M 956 215 3M 717 256 564 235 476 991 2M 690 407 3M 2M
generalAndAdministrativeExpenses 3M 3M 12M 3M 3M 3M 10M 4M 0 0 14M 0 14M 13M
sellingAndMarketingExpenses 5M 5M 12M 3M 3M 2M 9M 822 500 0 0 4M 0 4M 841 300
sellingGeneralAndAdministrativeExpenses 8M 9M 25M 7M 5M 5M 19M 5M 5M 5M 18M 5M 18M 14M
otherExpenses 0 0 0 0 1 0 0 -467 -5631 -31 -1101 0 -16 948 0
operatingExpenses 10M 11M 29M 8M 6M 6M 21M 6M 5M 5M 21M 5M 21M 15M
costAndExpenses 14M 14M 39M 10M 9M 8M 27M 7M 7M 6M 26M 7M 24M 18M
interestIncome 0 106 549 388 586 76 020 107 242 135 293 410 274 112 300 103 439 86 314 88 731 0 1612 0
interestExpense 9743 0 0 0 0 0 0 0 0 -51 879 0 4345 0 474 709
depreciationAndAmortization 434 629 428 447 776 971 0 101 377 88 343 517 681 127 222 159 786 167 663 542 627 156 722 335 963 108 670
ebitda -3M -4M -5M -957 553 -1M -4M -8M -2M -943 220 -3M -10M -3M -10M -11M
ebitdaratio -0.306 -0.431 -0.104 -0.135 -1.012 -0.399 -0.158 -0.726 -0.671
operatingIncome -4M -5M -6M -957 553 -1M -4M -8M -2M -1M -3M -11M -3M -10M -11M
operatingIncomeRatio -0.349 -0.476 -0.104 -0.148 -1.036 -0.399 -0.185 -0.775 -0.71
totalOtherIncomeExpensesNet -9743 106 549 388 586 76 020 107 242 135 296 239 986 -70 591 -18 145 69 081 21 119 12 307 -15 336 -1M
incomeBeforeTax -4M -4M -6M -881 533 -1M -4M -8M -2M -1M -3M -11M -3M -10M -12M
incomeBeforeTaxRatio -0.35 -0.465 -0.096 -0.134 -1 -0.39 -0.171 -0.755 -0.707
incomeTaxExpense 135 658 148 201 365 617 84 876 113 785 82 158 156 002 46 355 -3562 42 411 69 937 23 382 88 928 0
netIncome -4M -5M -6M -966 409 -1M -4M -8M -2M -1M -3M -11M -3M -10M -12M
netIncomeRatio -0.363 -0.48 -0.105 -0.149 -1.022 -0.399 -0.17 -0.767 -0.713
eps -0.09 -0.11 -0.16 -0.026 -0.03 -0.1 -0.28 -0.058 -0.036 -0.11 -1.52 -0.4 -1.78 -3.62
epsdiluted -0.09 -0.11 -0.026 -0.03 -0.1 -0.058 -0.036 -0.11 -0.4
weightedAverageShsOut 42M 42M 38M 38M 37M 37M 29M 35M 28M 24M 7M 7M 6M 3M
weightedAverageShsOutDil 42M 42M 38M 38M 37M 37M 29M 35M 28M 24M 7M 7M 6M 3M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-10 2024-03-08 2023-03-13 2022-03-11 2021-03-10
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 388 586 410 274 88 731 1612 -474 709
ebit -6M -8M -11M -10M -11M
nonOperatingIncomeExcludingInterest -388 586 0 0 0 586 516
netIncomeFromContinuingOperations -6M -8M -11M -10M -12M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -6M -8M -11M -11M -12M
epsDiluted -0.16 -0.28 -1.52 -1.78 -3.62

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-10 2025-08-11 2024-11-06 2024-08-06 2024-05-08 2023-11-07 2023-08-09 2023-05-10 2022-11-10
acceptedDate 2025-11-10 16:15:52 2025-08-11 16:15:27 2025-03-10 16:28:56 2024-11-06 16:15:23 2024-08-06 16:15:26 2024-05-08 16:10:58 2024-03-07 21:38:51 2023-11-07 17:29:50 2023-08-09 16:18:01 2023-05-10 16:24:01 2023-03-13 15:49:17 2022-11-10 16:28:57 2022-03-11 14:51:31 2021-03-10 16:21:17
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 13M 14M 24M 7M 6M 5M 7M 7M 6M 9M 5M 7M 16M 12M
shortTermInvestments 0 1M 492 990 0 3M 6M 2M 4M 3M 0 0 0 0 0
cashAndShortTermInvestments 13M 15M 25M 7M 9M 11M 9M 11M 9M 9M 5M 7M 16M 12M
netReceivables 5M 7M 4M 4M 3M 2M 2M 3M 2M 2M 2M 2M 2M 924 916
inventory 4M 4M 3M 3M 3M 2M 2M 1M 1M 2M 1M 1M 808 308 707 114
otherCurrentAssets 1M 1M 933 377 968 569 1M 676 787 598 850 920 076 694 641 535 558 573 462 553 696 -95 330 0
totalCurrentAssets 23M 28M 33M 15M 15M 16M 14M 16M 13M 13M 9M 11M 19M 14M
propertyPlantEquipmentNet 7M 10M 9M 466 962 828 801 810 814 839 348 887 894 452 837 597 651 703 026 844 915 908 195 263 807
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
goodwillAndIntangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
longTermInvestments 0 0 0 0 0 0 0 32 648 102 773 115 287 132 489 149 140 0 0
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 4M 661 670 539 412 1M 219 890 4954 91 237 91 237 111 034 111 034 111 034 111 034 95 330 0
totalNonCurrentAssets 11M 11M 9M 2M 1M 815 768 930 585 1M 666 644 823 972 946 549 1M 1M 263 807
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 34M 39M 42M 16M 16M 17M 15M 17M 13M 14M 10M 12M 20M 15M
accountPayables 0 3M 1M 0 1M 828 873 1M 5M 766 583 906 805 569 681 878 600 723 352 180 499
shortTermDebt 2M 3M 0 205 464 633 200 421 514 0 456 064 181 783 275 028 0 441 386 0 0
taxPayables 351 974 204 110 318 885 305 861 268 310 171 280 96 461 65 576 177 187 182 768 48 220 0 39 145 0
deferredRevenue 134 750 2M 2M 31 971 12 015 1M 8510 30 685 844 519 933 336 773 885 738 153 192 750 2812
otherCurrentLiabilities 7M 4M 5M 6M 4M 3M 3M 65 576 3M 2M 1M 2M 2M 2M
totalCurrentLiabilities 9M 12M 10M 7M 6M 6M 5M 6M 4M 4M 4M 4M 4M 3M
longTermDebt 10M 9M 0 29 165 47 338 64 599 0 253 210 139 657 169 770 0 220 901 0 0
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 126 312 498 685 1246 1495
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 0 0 0 0 -1 0 0 -1 0 0 0 -2M 0 118 060
totalNonCurrentLiabilities 10M 9M 7M 29 165 47 337 64 599 115 160 253 209 139 783 170 082 200 705 221 586 402 868 274 703
otherLiabilities 0 0 0 0 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 8M 8M 234 629 363 938 64 599 601 303 709 274 321 440 444 798 553 908 662 287 735 002 173 437
totalLiabilities 19M 21M 18M 7M 7M 6M 6M 6M 4M 4M 4M 4M 5M 3M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 3843 3778 3439 3026 3021 2881 2715 2652 2110 2092 775 706 687 457
retainedEarnings -115M -111M -103M -103M -102M -101M -97M -94M -92M -91M -89M -87M -78M -68M
accumulatedOtherComprehensiveIncomeLoss 137 653 48 334 -14 406 395 734 138 888 147 511 83 669 -8554 39 292 109 015 43 227 -11 466 -60 677 -12 690
othertotalStockholdersEquity 129M 129M 112M 111M 112M 105M 101M 101M 94M
totalStockholdersEquity 15M 18M 25M 9M 10M 11M 9M 11M 9M 10M 6M 8M 15M 12M
totalEquity 15M 18M 25M 9M 10M 11M 9M 11M 9M 10M 6M 8M 15M 12M
totalLiabilitiesAndStockholdersEquity 34M 39M 16M 16M 17M 17M 13M 14M 12M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 34M 39M 42M 16M 16M 17M 15M 17M 13M 14M 10M 12M 20M 15M
totalInvestments 0 1M 492 990 0 3M 6M 2M 4M 3M 115 287 132 489 149 140 0 0
totalDebt 12M 12M 8M 234 629 363 938 486 113 601 303 709 274 321 440 444 798 553 908 662 287 735 002 173 437
netDebt -256 597 -2M -16M -6M -5M -5M -6M -6M -6M -9M -5M -7M -15M -12M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-10 2024-03-08 2023-03-13 2022-03-11 2021-03-10
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 4M 2M 2M 2M 924 916
otherReceivables 0 0 0 0 0
prepaids 0 0 0 894 494 572 684
totalPayables 1M 1M 617 901 762 497 180 499
otherPayables 318 885 0 48 220 39 145 0
accruedExpenses 518 112 501 965 662 574 516 213 586 930
capitalLeaseObligationsCurrent 748 021 486 143 353 701 333 380 18 289
capitalLeaseObligationsNonCurrent 7M 115 160 200 207 401 622 155 148
treasuryStock -6464 -6464 -6464 -6464 -6464
additionalPaidInCapital 128M 106M 95M 94M 79M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO MYO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-10 2025-08-11 2024-11-06 2024-08-06 2024-05-08 2023-11-07 2023-08-09 2023-05-10 2022-11-10
acceptedDate 2025-11-10 16:15:52 2025-08-11 16:15:27 2025-03-10 16:28:56 2024-11-06 16:15:23 2024-08-06 16:15:26 2024-05-08 16:10:58 2024-03-07 21:38:51 2023-11-07 17:29:50 2023-08-09 16:18:01 2023-05-10 16:24:01 2023-03-13 15:49:17 2022-11-10 16:28:57 2022-03-11 14:51:31 2021-03-10 16:21:17
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -4M -5M -6M 5M -1M -4M -8M -2M -1M -3M -11M -3M -10M -12M
depreciationAndAmortization 434 629 428 447 776 971 -189 720 101 377 88 343 517 681 127 222 159 786 150 461 542 627 140 070 335 963 108 670
deferredIncomeTax 0 0 0 0 0 0 0 69 750 -3562 0 0 0 0 0
stockBasedCompensation 583 990 394 889 874 438 -228 395 -91 893 320 288 1M 330 425 280 061 171 027 1M 305 633 1M 614 302
changeInWorkingCapital 507 590 -5M 1M 563 253 -729 813 166 560 293 211 -174 703 336 064 426 903 -1M -461 613 -588 010 848 915
accountsReceivables 2M -2M -2M 102 234 -820 910 718 676 -495 599 -861 473 -104 656 340 533 47 445 -239 274 -1M -522 944
inventory 185 864 -653 968 -1M 816 055 -218 968 -597 087 -384 781 -159 007 226 055 -157 148 -607 400 -256 191 -118 222 -271 545
accountsPayables -1M -2M 5M -990 973 903 932 87 041 2M 1M 501 714 386 880 -711 898 0 0 1M
otherWorkingCapital -174 174 -53 952 -478 696 635 937 -593 867 -42 070 -616 542 -407 607 -287 049 -143 362 -178 129 33 852 576 494 425 475
otherNonCashItems 307 926 -38 443 -17 369 -7M 172 819 303 221 48 307 -38 484 -43 722 79 214 204 341 46 902 -19 727 959 128
netCashProvidedByOperatingActivities -2M -9M -3M -1M -2M -3M -6M -2M -285 523 -2M -10M -3M -10M -9M
investmentsInPropertyPlantAndEquipment -1M -1M -1M 179 173 -119 365 -59 808 -145 816 -54 093 -14 973 -45 085 -111 793 -5736 -326 462 -45 752
acquisitionsNet 0 0 0 0 0 0 0 1M 3M 0 -199 000 0 0 0
purchasesOfInvestments 0 0 -6M 0 0 -5M -6M -2M -3M 0 -199 000 0 0 0
salesMaturitiesOfInvestments 1M 500 000 8M 3M 2M 2M 4M 750 000 250 000 0 398 000 0 0 0
otherInvestingActivites 0 0 -499 877 2M -4M -1M -3M 0 0
netCashUsedForInvestingActivites 189 698 -757 348 3M 2M -4M -1M -3M -45 085 -5736
debtRepayment 0 4M 0 0 0 0 0 0 0
commonStockIssued 0 0 -5M 0 5M 6M 0 4M 0
commonStockRepurchased 0 0 0 5M -5M 0 0 -4M -8147 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -50 000 0 -199 500 5M 5M 2M 0 2M 0
netCashUsedProvidedByFinancingActivities -50 000 4M -199 500 0 5M 4M -8147 6M 0
effectOfForexChangesOnCash 2208 69 257 -26 439 13 697 -3337 -10 360 14 211 -13 921 3M 7311 -10 934 -11 434 -10 392 -1122
netChangeInCash -2M -6M 18M 1M 411 374 -1M 2M 905 464 -3M 4M -10M -3M 3M 8M
cashAtEndOfPeriod 13M 14M 25M 7M 6M 5M 7M 7M 6M 9M 5M 7M 16M 12M
cashAtBeginningOfPeriod 14M 20M 7M 6M 5M 7M 5M 6M 9M 5M 16M 10M 12M 5M
operatingCashFlow -2M -9M -3M -1M -2M -3M -6M -2M -285 523 -2M -10M -3M -10M -9M
capitalExpenditure -1M -1M -1M 179 173 -119 365 -59 808 -145 816 -54 093 -14 973 -45 085 -111 793 -5736 -326 462 -45 752
freeCashFlow -3M -10M -5M -1M -2M -3M -6M -2M -300 496 -2M -10M -3M -10M -9M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-10 2024-03-08 2023-03-13 2022-03-11 2021-03-10
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 -199 000 0 0
netCashProvidedByInvestingActivities 259 981 -2M -310 793 -326 462 -45 752
netDebtIssuance 0 0 0 0 -2M
longTermNetDebtIssuance 0 0 0 0 -2M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 20M 10M 376 858 1M 19M
netCommonStockIssuance 20M 10M 376 858 1M 19M
commonStockIssuance 20M 10M 376 858 1M 19M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 563 638 -8116 0 12M 185 298
netCashProvidedByFinancingActivities 21M 10M 376 858 13M 17M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2025 q3
2025-11-10 ET (fiscal 2025 q3)
2025 q2
2025-08-11 ET (fiscal 2025 q2)
2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-03-10 ET (fiscal 2024 q4)
2024 q3
2024-11-06 ET (fiscal 2024 q3)
2024 q2
2024-08-09 ET (fiscal 2024 q2)
2024 q1
2024-05-08 ET (fiscal 2024 q1)
2023 q4
2024-03-07 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-09 ET (fiscal 2023 q2)
2023 q1
2023-05-11 ET (fiscal 2023 q1)
2022 q4
2023-03-13 ET (fiscal 2022 q4)
2022 q3
2022-11-10 ET (fiscal 2022 q3)
2022 q2
2022-08-06 ET (fiscal 2022 q2)
2022 q1
2022-05-11 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-10 16:15 ET
Myomo reported for 2025 q3
SEC form 8
2025-08-11 20:15 ET
Myomo published news for 2025 q2
SEC form 8
2025-08-11 20:15 ET
Myomo reported for 2025 q2
SEC form 10
2025-08-11 20:15 ET
Myomo reported for 2025 q2
SEC form 8
2025-06-18 12:40 ET
Myomo published news for 2025 q1
SEC form 8
2025-06-18 12:40 ET
Myomo published news for 2025 q1
SEC form 10
2025-05-07 20:15 ET
Myomo reported for 2025 q1
SEC form 8
2025-05-07 20:10 ET
Myomo published news for 2025 q1
SEC form 8
2025-05-07 20:10 ET
Myomo reported for 2025 q1
SEC form 10
2025-05-07 00:00 ET
Myomo reported for 2025 q1
SEC form 10
2025-03-10 16:28 ET
Myomo reported for 2024 q4
SEC form 8
2025-03-10 16:10 ET
Myomo published news for 2024 q4
SEC form 8
2025-03-10 16:10 ET
Myomo reported for 2024 q4
SEC form 10
2025-03-10 00:00 ET
Myomo reported for 2024 q4
SEC form 10
2024-11-06 16:15 ET
Myomo reported for 2024 q3
SEC form 8
2024-11-06 16:10 ET
Myomo published news for 2024 q3
SEC form 8
2024-11-06 16:10 ET
Myomo reported for 2024 q3
SEC form 10
2024-08-06 16:15 ET
Myomo reported for 2024 q2
SEC form 8
2024-08-06 16:10 ET
Myomo published news for 2024 q2
SEC form 8
2024-08-06 16:10 ET
Myomo reported for 2024 q2
SEC form 10
2024-08-06 00:00 ET
Myomo reported for 2024 q2
SEC form 8
2024-07-08 00:00 ET
Myomo published news for 2024 q2
SEC form 8
2024-07-08 00:00 ET
Myomo published news for 2024 q2
SEC form 10
2024-05-08 00:00 ET
Myomo reported for 2024 q1
SEC form 8
2024-05-08 00:00 ET
Myomo published news for 2024 q1
SEC form 8
2024-05-08 00:00 ET
Myomo reported for 2024 q1
SEC form 10
2024-03-08 00:00 ET
Myomo reported for 2023 q4
SEC form 10
2024-03-07 21:38 ET
Myomo reported for 2023 q4
SEC form 8
2024-03-07 16:10 ET
Myomo published news for 2023 q4
SEC form 8
2024-03-07 16:10 ET
Myomo reported for 2023 q4
SEC form 10
2023-11-07 17:29 ET
Myomo reported for 2023 q3
SEC form 8
2023-11-07 16:15 ET
Myomo reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Myomo reported for 2023 q3
SEC form 10
2023-08-09 16:18 ET
Myomo reported for 2023 q2
SEC form 6
2023-08-09 16:11 ET
Myomo reported for 2023 q2
SEC form 10
2023-08-09 00:00 ET
Myomo reported for 2023 q2
SEC form 8
2023-08-09 00:00 ET
Myomo reported for 2023 q2
SEC form 6
2023-06-09 08:30 ET
Myomo published news for 2023 q1
SEC form 10
2023-05-10 00:00 ET
Myomo reported for 2023 q1
SEC form 8
2023-05-10 00:00 ET
Myomo reported for 2023 q1
SEC form 6
2023-04-10 08:46 ET
Myomo published news for 2023 q1
SEC form 10
2023-03-13 15:49 ET
Myomo reported for 2022 q4
SEC form 6
2023-03-13 08:40 ET
Myomo reported for 2022 q4
SEC form 10
2023-03-13 00:00 ET
Myomo reported for 2022 q4
SEC form 8
2023-03-13 00:00 ET
Myomo reported for 2022 q4
SEC form 6
2023-01-30 16:16 ET
Myomo published news for 2022 q4
SEC form 6
2023-01-13 17:17 ET
Myomo published news for 2022 q4
SEC form 6
2023-01-10 16:35 ET
Myomo published news for 2022 q4
SEC form 6
2022-12-07 16:16 ET
Myomo published news for 2022 q3
SEC form 10
2022-11-10 16:28 ET
Myomo reported for 2022 q3
SEC form 6
2022-11-10 16:22 ET
Myomo reported for 2022 q3
SEC form 10
2022-11-10 00:00 ET
Myomo reported for 2022 q3
SEC form 8
2022-11-10 00:00 ET
Myomo reported for 2022 q3
SEC form 6
2022-10-28 08:31 ET
Myomo published news for 2022 q3
SEC form 6
2022-10-18 17:01 ET
Myomo published news for 2022 q3
SEC form 6
2022-09-27 17:00 ET
Myomo published news for 2022 q2
SEC form 10
2022-08-03 16:17 ET
Myomo reported for 2022 q2
SEC form 6
2022-08-03 16:10 ET
Myomo published news for 2022 q2
SEC form 10
2022-08-03 00:00 ET
Myomo reported for 2022 q2
SEC form 8
2022-08-03 00:00 ET
Myomo reported for 2022 q2
SEC form 6
2022-08-02 17:19 ET
Myomo published news for 2022 q2
SEC form 6
2022-07-07 16:15 ET
Myomo published news for 2022 q2
SEC form 6
2022-06-10 16:06 ET
Myomo published news for 2022 q1
SEC form 10
2022-05-11 16:16 ET
Myomo reported for 2022 q1
SEC form 6
2022-05-11 16:10 ET
Myomo published news for 2022 q1
SEC form 10
2022-05-11 00:00 ET
Myomo reported for 2022 q1
SEC form 8
2022-05-11 00:00 ET
Myomo reported for 2022 q1
SEC form 6
2022-04-29 08:30 ET
Myomo published news for 2022 q1
SEC form 6
2022-04-04 16:31 ET
Myomo published news for 2022 q1
SEC form 10
2022-03-11 14:51 ET
Myomo published news for 2021 q4
SEC form 10
2022-03-11 00:00 ET
Myomo published news for 2021 q4
SEC form 6
2022-03-09 16:11 ET
Myomo published news for 2021 q4
SEC form 8
2022-03-09 00:00 ET
Myomo published news for 2021 q4
SEC form 6
2022-01-10 08:35 ET
Myomo published news for 2021 q4
SEC form 6
2022-01-05 16:16 ET
Myomo published news for 2021 q4
SEC form 6
2021-12-16 16:15 ET
Myomo published news for 2021 q3
SEC form 10
2021-11-10 16:48 ET
Myomo published news for 2021 q3
SEC form 6
2021-11-10 16:11 ET
Myomo published news for 2021 q3
SEC form 10
2021-11-10 00:00 ET
Myomo published news for 2021 q3
SEC form 8
2021-11-10 00:00 ET
Myomo published news for 2021 q3
SEC form 6
2021-10-15 09:25 ET
Myomo published news for 2021 q3
SEC form 6
2021-10-05 16:31 ET
Myomo published news for 2021 q3
SEC form 10
2021-08-09 16:17 ET
Myomo published news for 2021 q2
SEC form 6
2021-08-09 16:10 ET
Myomo published news for 2021 q2
SEC form 10
2021-08-09 00:00 ET
Myomo published news for 2021 q2
SEC form 6
2021-06-29 16:06 ET
Myomo published news for 2021 q1
SEC form 6
2021-06-25 16:17 ET
Myomo published news for 2021 q1
SEC form 6
2021-06-15 16:30 ET
Myomo published news for 2021 q1
SEC form 6
2021-06-08 08:30 ET
Myomo published news for 2021 q1
SEC form 10
2021-05-05 16:15 ET
Myomo published news for 2021 q1
SEC form 6
2021-05-05 16:10 ET
Myomo published news for 2021 q1
SEC form 10
2021-05-05 00:00 ET
Myomo published news for 2021 q1
SEC form 6
2021-04-28 17:01 ET
Myomo published news for 2021 q1
SEC form 6
2021-04-28 16:15 ET
Myomo published news for 2021 q1
SEC form 6
2021-04-16 17:01 ET
Myomo published news for 2021 q1
SEC form 6
2021-04-06 17:00 ET
Myomo published news for 2021 q1
SEC form 10
2021-03-10 16:21 ET
Myomo published news for 2020 q4
SEC form 6
2021-03-10 16:10 ET
Myomo published news for 2020 q4
SEC form 6
2021-01-26 06:46 ET
Myomo published news for 2020 q4
SEC form 6
2021-01-19 17:22 ET
Myomo published news for 2020 q4
SEC form 6
2021-01-11 06:41 ET
Myomo published news for 2020 q4
SEC form 6
2020-12-16 16:15 ET
Myomo published news for 2020 q3
SEC form 10
2020-11-10 16:17 ET
Myomo published news for 2020 q3
SEC form 6
2020-11-10 16:10 ET
Myomo published news for 2020 q3